
- Telehealth Visits
- Insurance plan information

Carolyn Rennels, MD
Palliative Medicine • Oncology Palliative Medicine- Telehealth Visits
- Insurance plan information



Carolyn Rennels, MD
Palliative Medicine • Oncology Palliative Medicine- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Carolyn Rennels is a specialist in palliative care who supports patients with serious illnesses by addressing their symptoms while upholding their values and goals. She is honored to walk with her patients on their health journeys and to be allowed a glimpse into their multifaceted lives.
Rennels' research has focused on caregiving, the patient experience (human perspectives on the health care they receive), and how doctors can deliver care in line with their patients' individual goals. She also has interests in the medical humanities (a field that integrates philosophical theories, the social sciences and the arts into medical education) and narrative medicine (an approach to care that incorporates both patients' and providers' unique stories related to a health concern). She loves teaching medical students, residents and fellows about palliative medicine and communication.
Rennels earned her medical degree at UCSF, where she also completed a residency in internal medicine and a fellowship in hospice and palliative medicine.
Rennels was born in the Bay Area. She loves spending time outdoors with her family.
Education & training
Board certification
- Hospice & Palliative Medicine, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Hospice & Palliative Medicine, UCSF Graduate Medical Education
Residency
- Internal Medicine, UCSF Graduate Medical Education
Degree
- MD, University of CA at San Francisco
My expertise
Locations
My research
Publications
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.